Cortivazol_NN
mediated_VBD
induction_NN
of_IN
glucocorticoid_NN
receptor_NN
messenger_NN
ribonucleic_JJ
acid_NN
in_IN
wild-type_JJ
and_CC
dexamethasone-resistant_JJ
human_JJ
leukemic_JJ
-LRB-_-LRB-
CEM_NN
-RRB-_-RRB-
cells_NNS
._.

Cortivazol_NN
is_VBZ
a_DT
phenylpyrazolo_JJ
glucocorticoid_NN
of_IN
high_JJ
potency_NN
and_CC
unusual_JJ
structure_NN
._.

In_IN
both_CC
wild-type_JJ
and_CC
highly_RB
dexamethasone_NN
-LRB-_-LRB-
dex_NN
-RRB-_-RRB-
-_:
resistant_JJ
clones_NNS
of_IN
the_DT
human_JJ
leukemic_JJ
cell_NN
line_NN
CEM_NN
,_,
exposure_NN
to_TO
cortivazol_NN
leads_VBZ
to_TO
cell_NN
death_NN
._.

It_PRP
has_VBZ
been_VBN
shown_VBN
recently_RB
that_IN
in_IN
wild-type_JJ
CEM_NN
cells_NNS
but_CC
not_RB
in_IN
a_DT
dex-resistant_JJ
,_,
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
-_:
defective_JJ
clone_NN
ICR-27_NN
TK-3_NN
,_,
dex_NN
induces_VBZ
GR_NN
mRNA_NN
._.

To_TO
test_VB
the_DT
hypothesis_NN
that_IN
cortivazol_NN
acts_VBZ
in_IN
dex-resistant_JJ
cells_NNS
by_IN
making_VBG
use_NN
of_IN
the_DT
residual_JJ
GR_NN
found_VBN
there_EX
,_,
wild-type_JJ
and_CC
dex-resistant_JJ
clones_NNS
were_VBD
treated_VBN
with_IN
various_JJ
concentrations_NNS
of_IN
cortivazol_NN
and_CC
induction_NN
of_IN
GR_NN
mRNA_NN
was_VBD
studied_VBN
._.

Cortivazol_NN
significantly_RB
induced_VBD
GR_NN
mRNA_NN
in_IN
the_DT
normal_JJ
CEM-C7_NN
as_RB
well_RB
as_IN
in_IN
two_CD
classes_NNS
of_IN
dex-resistant_JJ
clones_NNS
,_,
although_IN
the_DT
dex-resistant_JJ
clones_NNS
needed_VBD
at_IN
least_JJS
10_CD
times_NNS
more_RBR
cortivazol_NN
than_IN
the_DT
normal_JJ
cells_NNS
for_IN
significant_JJ
GR_NN
mRNA_NN
induction_NN
._.

Increased_VBN
levels_NNS
of_IN
GR_NN
mRNA_NN
were_VBD
noticed_VBN
as_RB
early_RB
as_IN
3_CD
h_NN
after_IN
treatment_NN
._.

A_DT
general_JJ
correlation_NN
between_IN
induction_NN
of_IN
GR_NN
mRNA_NN
and_CC
lysis_NN
of_IN
the_DT
normal_JJ
and_CC
dex-resistant_JJ
cells_NNS
was_VBD
found_VBN
._.

Positive_JJ
induction_NN
of_IN
GR_NN
mRNA_NN
might_MD
be_VB
one_CD
of_IN
the_DT
earliest_JJS
crucial_JJ
steps_NNS
in_IN
the_DT
lysis_NN
of_IN
normal_JJ
and_CC
dex-resistant_JJ
CEM_NN
cells_NNS
,_,
or_CC
might_MD
serve_VB
as_IN
a_DT
marker_NN
for_IN
the_DT
process_NN
._.

However_RB
,_,
the_DT
lysis_NN
pathway_NN
in_IN
the_DT
dex-resistant_JJ
cells_NNS
is_VBZ
defective_JJ
in_IN
that_IN
dex-resistant_JJ
clones_NNS
needed_VBD
significantly_RB
more_JJR
cortivazol_NN
than_IN
the_DT
normal_JJ
cells_NNS
for_IN
lysis_NN
of_IN
the_DT
cells_NNS
._.

